DRUGMAN-LECLERCQ. Les Maisons Campagnardes
0465.492.112 · rovalta.com · 27/09/2026
NORMAL SITUATION
DRUGMAN-LECLERCQ. Les Maisons Campagnardes
Company — Normal situation.
Financial year 2022 · Closed on 31/12/2022
Net result3,1 k €+125,8 %over 1 year
Gross margin86,8 k €+2 524,9 %over 1 year
Equity9,7 k €+47,6 %over 1 year
Overview
Identity
Source · BCE/KBODRUGMAN-LECLERCQ. Les Maisons Campagnardes is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0465.492.112
- Legal form
- Private limited company
- Contributed capital
- 18 592,01 €
- Latest accounts
- 31/12/2022
Joint committees (1)
- 124
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 24 filingsTrend over 17 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 86,8 k € | +2525% | -3,6 k € | -156% | 6,4 k € | -50.3% | 12,9 k € | -52.0% | 26,9 k € |
| EBITDA | 15,4 k € | +248% | -10,5 k € | -15.8% | -9 k € | -237% | 6,6 k € | -75.3% | 26,6 k € |
| Operating result | 14,6 k € | +228% | -11,4 k € | -24.6% | -9,2 k € | -243% | 6,4 k € | -75.6% | 26,3 k € |
| Net result | 3,1 k € | +126% | -12,1 k € | -59.4% | -7,6 k € | -220% | 6,4 k € | -76.0% | 26,4 k € |
| Balance sheet | |||||||||
| Equity | 9,7 k € | +47.6% | 6,6 k € | -64.9% | 18,7 k € | -28.9% | 26,3 k € | +31.8% | 19,9 k € |
| Total assets | 121,6 k € | +277% | 32,3 k € | -78.3% | 148,8 k € | +80.3% | 82,6 k € | +50.0% | 55 k € |
| Cash | 29,8 k € | +908% | 3 k € | -81.0% | 15,6 k € | +6.9% | 14,6 k € | +336% | 3,3 k € |
| Debts | 112 k € | +335% | 25,7 k € | -80.2% | 130,1 k € | +131% | 56,3 k € | +60.4% | 35,1 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20211 active · 3 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Marco Nyimec | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Jérôme Leclercq | Mandate | |
Jérôme Leclercq | Manager | |
Rombaud Drugman | Manager |
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Abridged model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/10/2023 | 15/03/2023 | 30/11/2021 | 24/09/2020 | 06/05/2019 | 02/03/2018 |
| General meeting | 30/04/2023 | 13/03/2023 | 30/06/2021 | 17/09/2020 | 30/04/2019 | 09/02/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 24 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2022 | 30/04/2023 | 03/10/2023 | French | |
| Micro model | 31/12/2021 | 13/03/2023 | 15/03/2023 | French | |
| Micro model | 31/12/2020 | 30/06/2021 | 30/11/2021 | French | |
| Micro model | 31/12/2019 | 17/09/2020 | 24/09/2020 | French | |
| Micro model | 31/12/2018 | 30/04/2019 | 06/05/2019 | French | |
| Abridged model | 31/12/2017 | 09/02/2018 | 02/03/2018 | French | |
| Abridged model | 31/12/2016 | 17/04/2017 | 27/04/2017 | French | |
| Abridged model | 31/12/2015 | 10/05/2016 | 19/05/2016 | French | |
| Abridged model | 30/12/2014 | 30/04/2015 | 21/05/2015 | French | |
| Abridged model | 31/12/2013 | 30/04/2014 | 03/07/2014 | French | |
| Abridged model | 31/12/2012 | 30/04/2013 | 22/08/2013 | French | |
| Abridged model | 31/12/2011 | 30/04/2012 | 31/07/2012 | French | |
| Abridged model | 31/12/2010 | 30/04/2011 | 12/05/2011 | French | |
| Abridged model | 31/12/2009 | 30/04/2010 | 27/07/2010 | French | |
| Abridged model | 31/12/2008 | 30/04/2009 | 20/05/2009 | French | |
| Abridged model | 31/12/2007 | 30/04/2008 | 19/08/2008 | French | |
| Abridged model | 31/12/2006 | 30/04/2007 | 30/07/2007 | French | |
| Abridged model | 31/12/2005 | 30/04/2006 | 16/06/2006 | French | |
| Abridged model | 31/12/2004 | 30/04/2005 | 16/09/2005 | French | |
| Abridged model | 31/12/2003 | 30/04/2004 | 18/08/2004 | French | |
| Abridged model | 31/12/2002 | 30/04/2003 | 10/06/2003 | French | |
| Abridged model | 31/12/2001 | 30/04/2002 | 13/08/2002 | French | |
| Abridged model | 31/12/2000 | 30/04/2001 | 15/06/2001 | French | |
| Abridged model | 31/12/1999 | 30/04/2000 | 08/05/2000 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20211 active · 3 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Marco Nyimec | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Jérôme Leclercq | Mandate | |
Jérôme Leclercq | Manager | |
Rombaud Drugman | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office09/05/2023SIEGE SOCIAL
- Mandates06/07/2020DENOMINATION - OBJET - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
- Mandates30/10/2019DEMISSIONS, NOMINATIONS
- Mandates03/05/2018SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Registered office27/01/2014SIEGE SOCIAL
- Mandates28/07/2010DEMISSIONS, NOMINATIONS
- Capital / shares08/04/2004ASSEMBLEE GENERALE - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 20223,1 k €↑
- 2022Name changeDRUGMAN
- 2021Annual accounts 2021-12,1 k €↓
- 2020Annual accounts 2020-7,6 k €↓
- 2019Annual accounts 20196,4 k €↓
- 2018Annual accounts 201826,4 k €↑
- 2017Annual accounts 2017-11,1 k €↓
- 2016Annual accounts 2016-6 k €↓
- 2015Annual accounts 201510,8 k €↑
- 2014Annual accounts 2014-8,2 k €↓
- 2013Annual accounts 201334,7 k €↑
- 2012Annual accounts 2012526 €↑
- 2011Annual accounts 2011-8,1 k €↓
- 2010Annual accounts 2010-745 €↑
- 2009Annual accounts 2009-67,5 k €↓
- 2008Annual accounts 20087,7 k €↓
- 2007Annual accounts 200716,7 k €↓
- 2006Annual accounts 200627,8 k €
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DRUGMAN | accounts 2022 | Accounts 2022 · 2023-00467825 |
| DRUGMAN-LECLERCQ. Les Maisons Campagnardes | accounts 2021 | Accounts 2021 · 2023-00041195 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.